Related Experiment Video
Updated: Jan 16, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
Intrahepatic Portosystemic Shunt Causing Hepatic Encephalopathy in a Non-cirrhotic Patient
Hailey J Carruthers1, Natalie M George2, Alexander Eskandarian1
1Department of Radiology, Wayne State University School of Medicine, Detroit, USA.
Abstract:
A 60-year-old woman presented with persistent nausea, new-onset tremulousness, and altered mental status. Abdominal and pelvic computed tomography (CT) revealed a large intrahepatic portosystemic connection, suspicious for a portal venous malformation. She underwent two image-guided embolization procedures. The first, via a transcaval approach, reduced shunt flow and improved ammonia levels. The second, using combined transhepatic and transfemoral access, achieved complete occlusion and led to sustained clinical improvement. This case underscores the importance of considering hepatic encephalopathy in non-cirrhotic patients with altered mental status and recognizing portosystemic shunts as a potential underlying cause.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

